Metropolitan Life Insurance Company (MetLife)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,989
Closed -$2.66M 919
2024
Q1
$2.66M Sell
7,989
-73
-0.9% -$22.3K 0.12% 158
2023
Q4
$2.18M Sell
8,062
-265
-3% -$65.5K 0.1% 171
2023
Q3
$2.05M Sell
8,327
-664
-7% -$182K 0.11% 163
2023
Q2
$2.73M Sell
8,991
-493
-5% -$137K 0.13% 137
2023
Q1
$2.5M Sell
9,484
-2,511
-21% -$638K 0.13% 143
2022
Q4
$2.88M Sell
11,995
-557
-4% -$125K 0.13% 155
2022
Q3
$2.31M Sell
12,552
-874
-7% -$174K 0.11% 177
2022
Q2
$2.26M Sell
13,426
-1,062
-7% -$228K 0.1% 197
2022
Q1
$3.63M Sell
14,488
-24,120
-62% -$6.06M 0.13% 151
2021
Q4
$9.92M Sell
38,608
-2,392
-6% -$585K 0.13% 118
2021
Q3
$9.95M Sell
41,000
-3,562
-8% -$871K 0.14% 111
2021
Q2
$9.21M Buy
44,562
+4,489
+11% +$915K 0.13% 125
2021
Q1
$7.55M Sell
40,073
-2,044
-5% -$360K 0.11% 149
2020
Q4
$6.93M Sell
42,117
-1,913
-4% -$280K 0.1% 155
2020
Q3
$5.49M Sell
44,030
-1,791
-4% -$222K 0.09% 170
2020
Q2
$4.45M Sell
45,821
-1,722
-4% -$179K 0.08% 200
2020
Q1
$4.27M Sell
47,543
-510
-1% -$66K 0.09% 183
2019
Q4
$7.1M Buy
48,053
+445
+0.9% +$59.8K 0.11% 157
2019
Q3
$5.73M Sell
47,608
-1,752
-4% -$226K 0.1% 185
2019
Q2
$6.67M Buy
49,360
+2,804
+6% +$355K 0.11% 158
2019
Q1
$6.07M Sell
46,556
-2,023
-4% -$272K 0.11% 157
2018
Q4
$6.05M Sell
48,579
-992
-2% -$133K 0.12% 149
2018
Q3
$6.9M Sell
49,571
-2,477
-5% -$308K 0.12% 155
2018
Q2
$5.34M Buy
52,048
+7,863
+18% +$796K 0.09% 198
2018
Q1
$4.29M Sell
44,185
-254
-0.6% -$24.6K 0.06% 239
2017
Q4
$3.9M Sell
44,439
-93,493
-68% -$7.51M 0.05% 268
2017
Q3
$11M Sell
137,932
-1,235
-0.9% -$99.3K 0.07% 256
2017
Q2
$12.1M Sell
139,167
-12,640
-8% -$1.07M 0.08% 225
2017
Q1
$13.5M Sell
151,807
-3,848
-2% -$321K 0.09% 205
2016
Q4
$11.5M Sell
155,655
-5,796
-4% -$434K 0.08% 229
2016
Q3
$12.2M Sell
161,451
-4,574
-3% -$350K 0.09% 215
2016
Q2
$12.8M Buy
166,025
+4,138
+3% +$327K 0.09% 205
2016
Q1
$12.6M Sell
161,887
-7,115
-4% -$497K 0.1% 199
2015
Q4
$11.4M Sell
169,002
-4,761
-3% -$332K 0.09% 224
2015
Q3
$13.4M Buy
173,763
+12,268
+8% +$1.09M 0.1% 199
2015
Q2
$14.7M Sell
161,495
-2,791
-2% -$224K 0.1% 190
2015
Q1
$12.4M Buy
164,286
+153,144
+1,374% +$11M 0.09% 229
2014
Q4
$818K Buy
11,142
+59
+0.5% +$4.15K 0.01% 1464
2014
Q3
$782K Buy
11,083
+213
+2% +$14.1K 0.01% 1430
2014
Q2
$613K Buy
10,870
+2,367
+28% +$125K ﹤0.01% 1687
2014
Q1
$446K Hold
8,503
﹤0.01% 1889
2013
Q4
$406K Hold
8,503
﹤0.01% 1950
2013
Q3
$364K Buy
8,503
+233
+3% +$9.1K ﹤0.01% 1970
2013
Q2
$298K Buy
+8,270
New +$320K ﹤0.01% 2049

Other funds holding HCA

Metropolitan Life Insurance Company (MetLife)'s HCA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 7,989 shares — an estimated $2.66M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HCA in Q2 2013 and held it in 44 quarters. The position peaked at $14.7M in Q2 2015. 1,156 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,989 HCA Healthcare shares in Q2 2024, an estimated $2.66M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in HCA Healthcare in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s HCA Healthcare position peaked at $14.7M in Q2 2015.
  • 1,156 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.